Advertisement Pathway Medical appoints new chairman - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pathway Medical appoints new chairman

Pathway Medical Technologies has named Paul Buckman as the new chairman of the board of directors.

Buckman is currently CEO and a director of Devax, a development-stage cardiovascular device company. Mr Buckman replaces Dan Galles, who has been acting board chairman since late 2006.

Dan Galles, former board chairman of Pathway Medical, said: “We are very pleased Paul has accepted the role of chairman. He brings an extensive range of industry experience to the Pathway board, including early commercialization experience. This is especially important to the company as it prepares for the launch of its first product, the Pathway PV Artherectomy System.”